NG25 trihydrochloride
Based on 24 publication(s) in Google Scholar
NG25 trihydrochloride is a dual TAK1 and MAP4K2 inhibitor (IC50: 149 nM and 21.7 nM respectively). NG25 sensitizes the breast cancer cells to Doxorubicin (HY-15142A), and enhances apoptosis. NG25 trihydrochloride can be used for research of various cancers.
For research use only. We do not sell to patients.
- CAS No.: 2108554-00-1
- Formula: C29H33Cl3F3N5O2
- Molecular Weight:646.96
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) NG25 trihydrochloride
More- Nat Cell Biol. 2017 Oct;19(10):1248-1259. [Abstract]
- Cell Death Differ. 2019 Dec;26(12):2520-2534. [Abstract]
- Int J Biol Sci. 2024 Jan 1;20(2):606-620. [Abstract]
- Cell Death Dis. 2022 Apr 30;13(4):421. [Abstract]
- Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2313148120. [Abstract]
- Oncogene. 2017 Oct 5;36(40):5620-5630. [Abstract]
- Sci Signal. 2018 Jul 10;11(538). pii: eaan5850. [Abstract]
- J Cell Biol. 2018 Aug 6;217(8):2727-2742. [Abstract]
- J Am Heart Assoc. 2021 Feb 16;10(4):e014311. [Abstract]
- Biofactors. 2020 Sep;46(5):813-820. [Abstract]
- J Mol Cell Cardiol. 2021 Feb;151:31-43. [Abstract]
- J Cell Mol Med. 2020 Sep;24(18):10946-10957. [Abstract]
- Sci Rep. 2016 Sep 7;6:32737. [Abstract]
- Mol Med Rep. 2018 Jan;17(1):1710-1716. [Abstract]
- J Immunol. 2015 Aug 1;195(3):1100-11. [Abstract]
- Biochem Biophys Res Commun. 2014 Oct 10;453(1):106-11. [Abstract]
- BMC Res Notes. 2022 Nov 26;15(1):352. [Abstract]
- Oncotarget. 2021 Oct 12;12(21):2158-2168. [Abstract]
- Universität Stuttgart. 2020 Sep.
- Norwegian University of Science and Technology. 2020 Jul.
- Oncotarget. 2017 Nov 1;8(61):104330-104346. [Abstract]
- Oncotarget. 2016 Oct 25;7(43):69173-69187. [Abstract]
- University of North Carolina. 2016.
- Harvard Medical School LINCS LIBRARY
-
WB
-
WB
-
WB
-
WB
-
WB
All MAP3K Isoforms
MoreAll MAP4K Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 2108554-00-1
-
Molecular Weight 646.96
-
Formula C29H33Cl3F3N5O2
-
SMILES
O=C(NC1=CC=C(CN2CCN(CC)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(OC4=C5C(NC=C5)=NC=C4)=C3.[H]Cl.[H]Cl.[H]Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (24)
-
Journal Impact Factor
-
Most Recent
-
Nat Cell Biol
p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. [Abstract]2017 Oct;19(10):1248-1259. PMID: 28920954
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Nat Cell Biol. 2017 Oct;19(10):1248-1259. [Abstract]
Immortalized RIPK1 +/+ fetal liver mouse macrophages were infected with YopP-negative Ye-ΔyopP in presence of inhibitors for TAK1 (NP, NG25), IKKβ, IKK, p38, MK2, JNK, or MEK1/ERK. The phosphorylation of RIPK1 is analyzed by immunoblotting in cell lysates prepared after 75 min of infection.
-
Cell Death Differ
TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma. [Abstract]2019 Dec;26(12):2520-2534. PMID: 30850732 -
Int J Biol Sci
TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver disease via nitric oxide production. [Abstract]2024 Jan 1;20(2):606-620. PMID: 38169654 -
Cell Death Dis
GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. [Abstract]2022 Apr 30;13(4):421. PMID: 35490166 -
Proc Natl Acad Sci U S A
ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars. [Abstract]2023 Dec 12;120(50):e2313148120. PMID: 38060563 -
Oncogene
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers. [Abstract]2017 Oct 5;36(40):5620-5630. PMID: 28581527
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Oncogene. 2017 Oct 5;36(40):5620-5630. [Abstract]
C3-TAg cells are starved and stimulated for 0, 15 and 30 min with ephrin-A1-Fc (EphA2 ligand; 1 μg/mL) in the presence or absence of ALW-II-41-27 or NG-25 control. EphA2 is immunoprecipitated and products probed for tyrosine phosphorylation and EphA2. ALW-II-41-27 significantly reduces basal and ephrin-A1-Fc induced tyrosine phosphorylation.
-
Sci Signal
IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells. [Abstract]2018 Jul 10;11(538). pii: eaan5850. PMID: 29991651
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Sci Signal. 2018 Jul 10;11(538). pii: eaan5850. [Abstract]
A549 cells are treated for 30 min with either 5z-7-oxozeanol or NG-25 to inhibit TAK1 and immunoblotted with the indicated antibodies.
-
J Cell Biol
Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs. [Abstract]2018 Aug 6;217(8):2727-2742. PMID: 29777026 -
J Am Heart Assoc
2021 Feb 16;10(4):e014311. PMID: 33522247 -
Biofactors
2020 Sep;46(5):813-820. PMID: 32525617 -
J Mol Cell Cardiol
FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway. [Abstract]2021 Feb;151:31-43. PMID: 32971071 -
J Cell Mol Med
Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway. [Abstract]2020 Sep;24(18):10946-10957. PMID: 32798288 -
Sci Rep
2016 Sep 7;6:32737. PMID: 27599572
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Sci Rep. 2016 Sep 7;6:32737. [Abstract]
TAK1 inhibition inhibits Dox-induced p38 activation and IκBα degradation. Breast cancer cell lines T-47D, MCF7, HCC1954, MDA-MB-231, and BT-549 are treated with Dox (20 μM) alone or combined with NG25 (2 μM) for 0, 2 h, 4 h or 6 h. The protein extracts are subjected to SDS-PAGE and immunoblotted with the antibodies against p-p38, p38, and IκBα. β-actin are detected as loading controls for whole cell extracts.
-
Mol Med Rep
NG25, an inhibitor of transforming growth factor‑β‑activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic‑ischemic rats. [Abstract]2018 Jan;17(1):1710-1716. PMID: 29138854
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Mol Med Rep. 2018 Jan;17(1):1710-1716. [Abstract]
Expression level of p TAK1 and downstream targets following NG25 treatment. Western blot detection of p TAK1 and TAK1 expression levels in the sham group, and samples from HI, DMSO treated and NG25 treated rat brain cortexes.
-
J Immunol
TLR8 Senses Staphylococcus aureus RNA in Human Primary Monocytes and Macrophages and Induces IFN-β Production via a TAK1-IKKβ-IRF5 Signaling Pathway. [Abstract]2015 Aug 1;195(3):1100-11. PMID: 26085680 -
Biochem Biophys Res Commun
Identification of TGF-β-activated kinase 1 as a possible novel target for renal cell carcinoma intervention. [Abstract]2014 Oct 10;453(1):106-11. PMID: 25261726
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2014 Oct 10;453(1):106-11. [Abstract]
786-O/A489 RCC cells are treated with LYTAK1 (100 nM), 5Z-7-oxozeanol (5Z, 0.25 lM) or NG-25 (NG-25, 2.5 lM) for 24 h, Western blots are applied to tested list proteins.
-
BMC Res Notes
2022 Nov 26;15(1):352. PMID: 36435864 -
Oncotarget
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan. [Abstract]2021 Oct 12;12(21):2158-2168. PMID: 34676048 -
-
-
Oncotarget
EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner. [Abstract]2017 Nov 1;8(61):104330-104346. PMID: 29262644
NG25 trihydrochloride purchased from MedChemExpress. Usage Cited in: Oncotarget. 2017 Nov 1;8(61):104330-104346. [Abstract]
MC38-CT or -CC1-L cells are treated with 1 μM of DMSO, or the non-specific NG-25 or specific ALW-II-41-27 EPHA2 receptor inhibitor for indicated periods of time, followed by stimulation with EFNA1-Fc (2 μg/mL) in the last 15 min of treatments. Protein lysates are prepared and subjected to immunoblotting using antibodies to determine the effect of kinase inhibitors on EPHA2 activation.
-
Oncotarget
2016 Oct 25;7(43):69173-69187. PMID: 27732951 -
-
Harvard Medical School LINCS LIBRARY
Purity & Documentation
References
[1]. Tan L, et al. Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2). J Med Chem. 2015 Jan 8;58(1):183-96. [Content Brief]
[2]. Wang Z, et al. TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells. Sci Rep. 2016 Sep 7;6:32737. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)